Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
Martina Rauner, Hanna Taipaleenmäki, Elena Tsourdi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 787-787
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Long-term and sequential treatment for osteoporosis
Ines Foessl, Hans Peter Dimai, Barbara Obermayer‐Pietsch
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 520-533
Closed Access | Times Cited: 115
The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities
Michael S. Yu, Kevin Qin, Jiaming Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101026-101026
Open Access | Times Cited: 41
The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
Dalia Ali, Michaela Tencerová, Florence Figeac, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 68
Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal
Biao Yu, Qianmin Gao, Shihao Sheng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview
Sotirios Tetradis, Matthew R. Allen, Salvatore L. Ruggiero
JBMR Plus (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 18
Setrusumab for the Treatment of Osteogenesis Imperfecta: 12-Month Results from the Phase 2b Asteroid Study
Francis H. Glorieux, Bente Langdahl, Roland Chapurlat, et al.
Journal of Bone and Mineral Research (2024) Vol. 39, Iss. 9, pp. 1215-1228
Closed Access | Times Cited: 7
Determination of SWCNT biosensor for bisphosphonate–2X(X = Mg2+, Ca2+, Sr2+) delivery in bone cell through electromagnetic and thermodynamic analysis using QM/MC methods
Fatemeh Mollaamin, Majid Monajjemi
Sensor Review (2024) Vol. 44, Iss. 2, pp. 100-112
Closed Access | Times Cited: 6
Microgravity-Related Changes in Bone Density and Treatment Options: A Systematic Review
Ronni Baran, Markus Wehland, Herbert Schulz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8650-8650
Open Access | Times Cited: 27
Immunomodulatory effects and mechanisms of distraction osteogenesis
Shude Yang, Ning Wang, Yutong Ma, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Application of DFT/TD-DFT Frameworks in the Drug Delivery Mechanism: Investigation of Chelated Bisphosphonate with Transition Metal Cations in Bone Treatment
Fatemeh Mollaamin, Majid Monajjemi
Chemistry (2023) Vol. 5, Iss. 1, pp. 365-380
Open Access | Times Cited: 15
Anabolic therapy for osteoporosis: update on efficacy and safety
Leonardo Bandeira, E. Michael Lewiecki
Archives of Endocrinology and Metabolism (2022) Vol. 66, Iss. 5, pp. 707-716
Open Access | Times Cited: 22
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment
Giovanni Iolascon, Sara Liguori, Marco Paoletta, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 11
Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/β-catenin signaling
Ri-Xu Liu, Ronghe Gu, Zhipeng Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Distal Radius Fractures
Joanne Zhang, Jason Strelzow
Springer eBooks (2024), pp. 1-29
Closed Access | Times Cited: 4
Carbonate Apatite Honeycomb Scaffold-Based Drug Delivery System for Repairing Osteoporotic Bone Defects
Koichiro Hayashi, Cheng Zhang, Ahmad Nazir Taleb Alashkar, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 35, pp. 45956-45968
Open Access | Times Cited: 4
Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Shih‐Hao Cheng, William Chu, Wen-Hsiang Chou, et al.
Drug Safety (2024)
Open Access | Times Cited: 4
VGF and the VGF-derived peptide AQEE30 stimulate osteoblastic bone formation through the C3a receptor
Sung-Ah Moon, Jin‐Man Kim, Young‐Sun Lee, et al.
Experimental & Molecular Medicine (2025)
Open Access
Can AI reveal the next generation of high-impact bone genomics targets?
Casey S. Greene, Christopher R. Gignoux, Marc Subirana-Granés, et al.
Bone Reports (2025), pp. 101839-101839
Open Access
Carbon Nanotubes as Biosensors for Releasing Conjugated Bisphosphonates–Metal Ions in Bone Tissue: Targeted Drug Delivery through the DFT Method
Fatemeh Mollaamin, Majid Monajjemi
C – Journal of Carbon Research (2023) Vol. 9, Iss. 2, pp. 61-61
Open Access | Times Cited: 10
Osteoporosis: Spotlight on current approaches to pharmacological treatment
Dilşad Sindel
Turkish Journal of Physical Medicine and Rehabilitation (2023) Vol. 69, Iss. 2, pp. 140-152
Open Access | Times Cited: 8
Atypical femur fracture following romosozumab and bisphosphonate treatment
Mark Jacunski, Hanna Johnsson, Stuart H. Ralston, et al.
The Journal of the Royal College of Physicians of Edinburgh (2024)
Closed Access | Times Cited: 2
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
Margarita M. Ivanova, Julia Dao, Neil Kasaci, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
Telomere length as a predictive biomarker in osteoporosis (Review)
Fotios Kakridonis, Spyros G. Pneumatikos, Elena Vakonaki, et al.
Biomedical Reports (2023) Vol. 19, Iss. 5
Open Access | Times Cited: 6
Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection – A post-treatment re-initiation bone biopsy-based case study
Louise Drejer Jensen, Bilal Mohamad El-Masri, Charlotte Ejersted, et al.
Bone Reports (2023) Vol. 19, pp. 101703-101703
Open Access | Times Cited: 5
Biofabrication of an in-vitro bone model for Gaucher disease
Dishary Banerjee, Margarita M. Ivanova, Nazmiye Celik, et al.
Biofabrication (2023) Vol. 15, Iss. 4, pp. 045023-045023
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top